---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033393"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2026-07-15T21:20:18+00:00"
generated_at: "2026-07-15T21:22:05.923372+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Glucotrack completes reverse merger with Lokahi; existing holders get 10% floor

## Summary
- Lokahi shareholders receive 90% of fully diluted equity; existing Glucotrack holders get at least 10%.
- CEO Paul Goode resigns; Erik Emerson appointed CEO and board member effective July 14, 2026.
- Bridge financing of $4.45M via senior secured convertible notes and warrants closed same day.
- Subsidiary contribution of $7M to Operating Sub for diabetes business, released in installments.
- Post-closing: proxy statement for stockholder approval and Nasdaq listing of conversion shares.

## SEC filing metadata
- accession: 0001493152-26-033393
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2026-07-15T21:20:18+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315226033393/0001493152-26-033393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315226033393/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033393
- JSON: https://secwatch.observer/filing/0001493152-26-033393.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033393.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.